PubMed

Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.

Fung AT, Reid SE, Jones MP, Healey PR, McCluskey PJ, Craig JC.

Br J Ophthalmol. 2007 Jan;91(1):62-8. Epub 2006 Sep 6. Review.PMID: 16956912 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma.

Loon SC, Liew G, Fung A, Reid SE, Craig JC.

Clin Experiment Ophthalmol. 2008 Apr;36(3):281-9.PMID: 18412600 [PubMed - indexed for MEDLINE]Related articles

A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.

DuBiner HB, Mroz M, Shapiro AM, Dirks MS; Brimonidine vs. Latanoprost Study Group.

Clin Ther. 2001 Dec;23(12):1969-83.PMID: 11813932 [PubMed - indexed for MEDLINE]Related articles

Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.

Simmons ST, Earl ML; Alphagan/Xalatan Study Group.

Ophthalmology. 2002 Feb;109(2):307-14; discussion 314-5.PMID: 11825814 [PubMed - indexed for MEDLINE]Related articles

Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

Simmons ST, Samuelson TW.

Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure-lowering effects of latanoprost and brimonidine therapy in patients with open-angle glaucoma or ocular hypertension: a randomized observer-masked multicenter study.

Kampik A, Arias-Puente A, O'Brart DP, Vuori ML; European Latanoprost Study Group.

J Glaucoma. 2002 Apr;11(2):90-6.PMID: 11912355 [PubMed - indexed for MEDLINE]Related articles

Latanoprost or brimonidine as treatment for elevated intraocular pressure: multicenter trial in the United States.

Camras CB, Sheu WP; United States Latanoprost-Brimonidine Study Group.

J Glaucoma. 2005 Apr;14(2):161-7.PMID: 15741820 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.

Zhang WY, Po AL, Dua HS, Azuara-Blanco A.

Br J Ophthalmol. 2001 Aug;85(8):983-90.PMID: 11466259 [PubMed - indexed for MEDLINE]Related articlesFree article

Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension.

Mundorf T, Noecker RJ, Earl M.

Adv Ther. 2007 Mar-Apr;24(2):302-9.PMID: 17565920 [PubMed - indexed for MEDLINE]Related articles

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension.

Simmons ST; Alphagan/Trusopt Study Group.

Clin Ther. 2001 Apr;23(4):604-19.PMID: 11354394 [PubMed - indexed for MEDLINE]Related articles

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.

Liu CJ, Ko YC, Cheng CY, Chiu AW, Chou JC, Hsu WM, Liu JH.

Ophthalmology. 2002 Dec;109(12):2241-7.PMID: 12466165 [PubMed - indexed for MEDLINE]Related articles

Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.

Stewart WC, Day DG, Stewart JA, Holmes KT, Leech JN, Rowan CT, Schwartz GF.

J Ocul Pharmacol Ther. 2000 Dec;16(6):557-64.PMID: 11132902 [PubMed - indexed for MEDLINE]Related articles

Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.

Sponsel WE, Paris G, Trigo Y, Pena M, Weber A, Sanford K, McKinnon S.

Am J Ophthalmol. 2002 Jan;133(1):11-8.PMID: 11755835 [PubMed - indexed for MEDLINE]Related articles

Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.

Stewart WC, Sharpe ED, Day DG, Kolker AE, Konstas AG, Lee WH, Rieser JC, Chopra H, Holmes KT.

J Ocul Pharmacol Ther. 2000 Jun;16(3):251-9.PMID: 10872922 [PubMed - indexed for MEDLINE]Related articles

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J.

Br J Ophthalmol. 2009 Mar;93(3):316-21. Epub 2008 Nov 19. Review.PMID: 19019922 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

Aptel F, Cucherat M, Denis P.

J Glaucoma. 2008 Dec;17(8):667-73.PMID: 19092464 [PubMed - indexed for MEDLINE]Related articles

Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.

Zabriskie N, Netland PA; Brimonidine with Latanoprost Study Groups 1 and 2.

Adv Ther. 2003 Mar-Apr;20(2):92-100.PMID: 12836809 [PubMed - indexed for MEDLINE]Related articles

Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.

Li N, Chen XM, Zhou Y, Wei ML, Yao X.

Clin Experiment Ophthalmol. 2006 Nov;34(8):755-64.PMID: 17073898 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.

Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE.

Am J Ophthalmol. 2001 May;131(5):631-5.PMID: 11336939 [PubMed - indexed for MEDLINE]Related articles